Lobbying client · LD-2 disclosures
Q Therapeutics, Inc.
Utah
3 filings from 1 registrant · 2010 · latest filed Oct 6, 2010
Reported on its behalf
$50K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$50K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Budget/Appropriations
BUD
3 filings
$50K on those filings
Defense
DEF
3 filings
$50K on those filings
Medical/Disease Research/Clinical Labs
MED
Who did the lobbying
Every lobbyist named on this client's filings.
- Michael Werner Holland & Knight LLPCovered position: 91-93; Policy Advisor, Senate Democratic Policy Committee4 filingsthrough 2010
- Santiago Vaca Holland & Knight LLP3 filingsthrough 2010
Covered positions · 1 of 2 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: q-therapeutics-inc.